Clinical Trials Logo

Filter by:
NCT ID: NCT05344053 Recruiting - Clinical trials for Coronary Artery Disease

Community-based Precise Management for Patients With Coronary Artery Disease

Start date: May 1, 2022
Phase: N/A
Study type: Interventional

The community-based precise management for patients with coronary artery disease study is a prospective, cluster-randomized, open-labeled trial. The purpose of this trial is to test whether a community-based precise management and rehabilitation model under the hierarchical medical system could help improve the cardiovascular risk factors control in patients with coronary artery disease. Additionally, the trial will also evaluate the impact of the model on major cardiovascular adverse events in patients with coronary artery disease.

NCT ID: NCT05343325 Recruiting - Clinical trials for Head and Neck Squamous Cell Carcinoma

The Efficacy and Safety of Neoadjuvant Low-dose Radiotherapy Combined With Chemoimmunotherapy in Locally Advanced HNSCC

Start date: March 9, 2022
Phase: Phase 2
Study type: Interventional

This is an open-label, single-arm, phase II clinical trial to explore the efficacy and safety of neoadjuvant low-dose radiotherapy combined with chemoimmunotherapy in resectable locally advanced head and neck squamous cell carcinoma. The eligible patients are scheduled to administered neoadjuvant low-dose radiotherapy, tislelizumab, combined with albumin-bound paclitaxel and cisplatin for two cycles. Radical resection will be performed in 3-4 weeks after two cycles of neoadjuvant therapy. The overall primary study hypothesis is that the novel neoadjuvant combination regime improves the pathological complete response (pCR) rate, with tolerable side effects.

NCT ID: NCT05343117 Recruiting - Clinical trials for Hormone Receptor Positive Advanced Breast Cancer

Comparative Effectiveness of PAL Based-therapy as Initial ET Versus PAL Based-therapy After ChT for HR+/HER2- ABC

Start date: December 1, 2021
Phase:
Study type: Observational

A multi-center non-interventional observational study led by the Cancer Hospital Chinese Academy of Medical Sciences to compare the effectiveness of palbociclib based-therapy as initial endocrine therapy versus palbociclib based-therapy after chemotherapy for HR+/HER2- advanced breast cancer.

NCT ID: NCT05343104 Recruiting - MRI Clinical Trials

Osteoarthrosis on 7.0T Magnetic Resonance Imaging

Start date: April 1, 2022
Phase:
Study type: Observational

This clinical trial studies the use of 7-Tesla (7T)and 3T magnetic resonance imaging (MRI) in detecting osteoarthrosis. 7T MRI has increased detection sensitivity, including more accurate lesion delineation, higher inter-rater agreement. Diagnostic procedures such as 7T MRI may help ultimately improved diagnostic and therapies confidence to inform decision making than standard 3T MRI.

NCT ID: NCT05342987 Recruiting - Sleep Quality Clinical Trials

Circadian Rhythm and Delirium in ICU

Start date: February 15, 2022
Phase:
Study type: Observational

The study aims to investigate the status of circadian rhythm and sleep quality in ICU patients and their influence factors. And explore the pathway of circadian rhythm on ICU delirium. The hypothesis of study is that icu patients experience circadian and sleep rhythm disorder, especially in patient who have delirium.

NCT ID: NCT05342792 Recruiting - Clinical trials for Nasopharyngeal Carcinoma

Metronomic Capecitabine With or Without PD-1 Antibody as Adjuvant Therapy in High-risk Nasopharyngeal Carcinoma

Start date: April 17, 2022
Phase: Phase 3
Study type: Interventional

This trial is aimed to investigate whether additional adjuvant PD-1 antibody treatment could improve survival in high-risk nasopharyngeal carcinoma compared to metronomic capecitabine alone.

NCT ID: NCT05342740 Recruiting - Diabetes Mellitus Clinical Trials

Study of Biomarkers in Diabetic Chronic Wounds

Start date: July 1, 2023
Phase:
Study type: Observational

This study aims to discover, verify and evaluate the potential biomarkers with regard to the diagnosis, prognostic and/or prediction of diabetic chronic wounds.

NCT ID: NCT05342714 Recruiting - Clinical trials for Cerebral Artery Occlusion

Remote Ischemic Conditioning for Chronic Cerebral Artery Occlusion

Start date: April 22, 2022
Phase: N/A
Study type: Interventional

Chronic cerebral artery occlusion (CCAO), which is characterized by the pathophysiological change of long-term cerebral hemodynamic disorder, is one of the major risk factors affect the occurrence and recurrence of ischemic stroke. However, the mechanism of CCAO injury is not clear and effective treatment is warranted. The purpose of this study is to investigate the protective effect and underlying mechanism of remote ischemic conditioning (RIC) on CCAO.

NCT ID: NCT05342233 Recruiting - Clinical trials for Spontaneous Isolated Superior Mesenteric Artery Dissection

Comparison of Conservative and Endovascular Treatment for Spontaneously Isolated Superior Mesenteric Artery Dissection

Start date: April 30, 2022
Phase:
Study type: Observational [Patient Registry]

Spontaneous isolated superior mesenteric artery dissection(SISMAD) is an increasingly diagnosed disease. However, prospective, multicenter studies that can provide evidence to support clinical decisions are very limited. This study aims to compare the therapeutic efficacy of conservative and endovascular treatment for SISMAD.

NCT ID: NCT05341583 Recruiting - Clinical trials for Non-small Cell Lung Cancer

Ensartinib as Adjuvant Treatment in Anaplastic Lymphoma Kinase (ALK) Positive Non-small Cell Lung Cancer

Start date: May 24, 2022
Phase: Phase 3
Study type: Interventional

This double-blind, randomized, placebo-controlled, multicenter, Phase III study is designed to evaluate the efficacy and safety of ensatinib compared with placebo as adjuvant treatment in ALK positive stage II-IIIB non-small cell lung cancer after surgical resection with or without chemotherapy.